Brad Loncar, Loncar Investments- #PreMarket Prep for Oct. 28, 2015

Listen to the show live every morning here: premarket.benzinga.com/pre-market-prep Brad Loncar is an independent biotechnology investor and Chief Executive Officer of Loncar Investments, LLC. He launched the LCINDX Index in March of 2015, and the Loncar Cancer Immunotherapy ETF (CNCR) listed on the NASDAQ stock market in October. Mr. Loncar incorporates his extensive research into biotech companies and technologies to develop indexes focused on precise investment opportunities. He previously worked in the financial services industry at Franklin Templeton Investments, and was appointed to serve in a Senior Adviser role at the U.S. department of the Treasury.